Entry into New Businesses, Including Medical Beds
First written in FY2016. 6 of 10 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2025.
1 other company's latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「In addition, following the consolidation of やまと産業株式会社, which processes and sells urethane foam products, as a subsidiary in April 2024, sales in this market for the consolidated fiscal year amounted to ¥1,509 million, compared with ¥51 million on a standalone basis in the previous fiscal year.」
Following the consolidation of やまと産業株式会社 as a subsidiary, full-year sales in bed-related and new business areas, including mattresses, reached ¥1,509 million, demonstrating the contribution of the new business area to results. - FY2025-H1AdvancedAnnual report
「Regarding electric beds for medical and long-term care use in the furniture distribution market, demand has continued to decline, as with ordinary beds. In addition, following the consolidation of やまと産業株式会社, which processes and sells urethane mattresses, as a subsidiary in April 2024, sales in this market for the interim consolidated period amounted to ¥811 million, compared with ¥26 million on a standalone basis in the previous fiscal year.」
Following the consolidation of やまと産業株式会社 as a subsidiary, interim sales in the furniture distribution market increased to ¥811 million from ¥26 million on a standalone basis in the previous fiscal year. This demonstrates progress in expanding bed-related products and new business areas through the mattress business. - FY2024-Q3AdvancedAnnual report
「Through the acquisition of these shares and the establishment of a subsidiary, the Group will simultaneously strengthen its mattress business, which complements its electric beds for medical and long-term care use, and expand into the manufacture and sale of mattresses for individual consumers (BtoBtoC), the core business of やまと産業株式会社. In doing so, the Group will seek to improve the growth potential and profitability of the corporate group and enhance corporate value.」
The Group acquired all shares of やまと産業株式会社 on 30 April 2024, making it a wholly owned subsidiary. This represents concrete progress in expanding bed-related products and new business areas through the strengthening of the mattress business and expansion into manufacturing and sales for individual consumers. - FY2023RestatedAnnual report
「In addition to traditional bed-related products such as mattresses, the Group will plan and develop products in new fields and expand its product lineup and business areas, thereby securing revenue sources beyond beds and building a stable earnings structure.」
The Group continues to indicate its policy of planning and developing products in new fields in addition to bed-related products, thereby diversifying its revenue sources. - FY2019RestatedAnnual report
「Going forward, the Group will pursue business initiatives such as developing products suited to the long-term care needs of each country and building a strong distributor network, while seeking to expand the market by establishing a sales structure for hospital beds over the medium term.」
The Group continues to indicate its policy of expanding into new areas, including medical and hospital beds, and its plan to establish a sales structure for hospital beds over the medium term. - FY2018AdvancedAnnual report
「The Group initially began sales activities in Fukuoka Prefecture, where its head office is located, then assigned dedicated sales staff to the Kansai area in September 2017 and the Kanto area in July 2018. The Group will continue expanding its sales territory, particularly in metropolitan areas, to increase earnings.」
For electric beds for hospitals, the area in which dedicated sales personnel were assigned was expanded from Fukuoka Prefecture to Kansai and then Kanto. - FY2017AdvancedAnnual report
「In addition, as sales of the Rafio electric bed for long-term care use, launched in January 2017, were strong, sales in this market for the consolidated fiscal year increased 18.0% from the same period of the previous year to ¥3,984 million.」
Strong sales following the launch of Rafio were reflected in the full-year results, with sales in the welfare equipment distribution market increasing 18.0% to ¥3,984 million. - FY2017-Q3AdvancedAnnual report
「As sales of the Rafio electric bed for long-term care use, launched in January 2017, were strong, sales in this market for the first 3 quarters of the consolidated fiscal year increased 5.4% from the same quarter of the previous year to ¥2,694 million.」
Rafio, whose launch had been postponed, was launched in January 2017 and was reported to be selling well. Sales in the welfare equipment distribution market also increased 5.4% year on year. - FY2017-Q2SoftenedAnnual report
「The new Rafio electric bed for medical and long-term care use, scheduled for launch in November 2016, was postponed until January 2017, which affected」
The launch of the new Rafio product was postponed from November 2016 to January 2017. - FY2016First statedAnnual report
「Leveraging the manufacturing technology and expertise the Group has developed in the long-term care industry, the Group launched the P300 Series electric beds for medical and institutional use in August 2016 and began entering the medical bed market. The Group will further strengthen its initiatives in these new businesses.」
The company also referred to the launch of medical beds and the expansion of its product lineup, including wandering detection devices.